Projects funded by the NCN

Cuproptosis, a novel pathway of regulated cell death as a therapeutic target in treatment-naïve and targeted therapy-res...

Call: OPUS 25 , Panel: NZ5

Principal investigator: dr hab. Mariusz Łukasz Hartman

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Changes in lipid metabolism of resistant to BRAF/MEK inhibitors human melanoma cells associated with the presence of adi...

Call: SONATA 16 , Panel: NZ5

Principal investigator: dr Aleksandra Simiczyjew

Uniwersytet Wrocławski, Wydział Biotechnologii

The significance of cancer specific PFK-II (PFKFB3 and PFKFB4) isoenzymes inhibition in overcoming resistance to BRAF in...

Call: PRELUDIUM 16 , Panel: NZ5

Principal investigator: Sonia Elżbieta Trojan

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum

Analysis of let-7 family miRNA expression in the context of BRAF mutation and potencial use of cf-DNA and miRNA in liqui...

Call: PRELUDIUM 15 , Panel: NZ2

Principal investigator: Ewelina Perdas

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Functional study of rare BRAF mutations on liver cancer development using CRISPR/Cas9 system

Call: PRELUDIUM 13 , Panel: NZ5

Principal investigator: Magdalena Śmiech

Instytut Genetyki i Hodowli Zwierząt PAN

Inhibitors of anti-apoptotic proteins from the BCL-2 family as agents enhancing BRAFV600E inhibition in melanoma cells.

Call: SONATA 12 , Panel: NZ7

Principal investigator: dr Mariusz Hartman

Uniwersytet Medyczny w Łodzi, Międzywydziałowa Katedra Chemii i Biochemii Medycznej

Long non-coding RNAs (lncRNA) as treatment efficacy markers in patients with advanced melanoma harboring BRAF mutation.

Call: OPUS 11 , Panel: NZ7

Principal investigator: dr hab. Jacek Mackiewicz

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Nauk o Zdrowiu

Zastosowanie techniki SERS do wykrywania mutacji genu BRAF

Call: FUGA 5 , Panel: ST4

Principal investigator: dr Aleksandra Maria Jaworska

Uniwersytet Warszawski, Wydział Chemii

Molecular mechanisms linking BRAF mutations and the expression of immunoregulatory molecules, galectin-1 and PD-L1 in me...

Call: PRELUDIUM 8 , Panel: NZ5

Principal investigator: Maja Magdalena Wasylecka-Juszczyńska

Instytut Hematologii i Transfuzjologii

Molecular aspects of RAS-related disorders in Polish population

Call: PRELUDIUM 2 , Panel: NZ2

Principal investigator: Magdalena Pelc

INSTYTUT - POMNIK - CENTRUM ZDROWIA DZIECKA